Arthralgia Clinical Trial
Official title:
Impact of 'Recovery' Footwear on Lower Extremity Comfort and Biomechanics
NCT number | NCT04830540 |
Other study ID # | 1826 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | February 8, 2021 |
Est. completion date | January 31, 2022 |
Verified date | February 2021 |
Source | University of Massachusetts, Amherst |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of this study is to understand the impact of wearing shoes with a compliant, energy absorbing midsole material, outside of athletic training sessions on the mechanics of movement, performance, and perceived joint pain and stiffness. Advances in material science have led to a wider range of cushioning system material properties and mid and outsole geometries in footwear. While there are many marketing claims about the potential health benefits of this new class of footwear these have not yet been investigated in well-designed scientific studies. It is hypothesized that the intervention shoe as compared to the control will reduce self-reported joint pain and stiffness, improve ankle plantarflexion function and increase intersegmental foot motion during walking.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | January 31, 2022 |
Est. primary completion date | January 31, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 30 Years |
Eligibility | Inclusion Criteria: - BMI 18 - 35 kg/m2. - Stiff or cleated footwear athlete on a competitive team. Exclusion Criteria: - Current injury that required absence from one or more practices in the last 3 weeks of regular team practice. - Orthotic or other shoe insert used outside of athletic training times. |
Country | Name | City | State |
---|---|---|---|
United States | Musculoskeletal & Orthopedic Biomechanics Laboratory/ University of Massachusetts Amherst | Amherst | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
University of Massachusetts, Amherst |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Calf Muscles Strength | Unilateral isometric and isokinetic strength based on maximal contractions performed on a dynamometer. | 2 - 3 hours on week 1 | |
Primary | Calf Muscles Strength | Unilateral isometric and isokinetic strength based on maximal contractions performed on a dynamometer. | 2 - 3 hours on week 6. | |
Primary | Gait Mechanics | Gait kinematics during overground walk at preferred speed, and 1.4m/s, evaluated with a motion capture system. | Gait analysis test at week 1 with 5 trials of overground walking at a speed of 1.4 m/s | |
Primary | Gait Mechanics | Gait kinematics during overground walk at preferred speed, and 1.4m/s, evaluated with a motion capture system. | Gait analysis test at week 6 with 5 trials of overground walking at a speed of 1.4 m/s | |
Primary | Muscle EMG activity | Unilateral Surface Electromyography of Medial Gastrocnemius, Lateral Gastrocnemius, Vastus Medialis, Vastus Lateralis, Tibialis Anterior, Peroneus Longus, Soleus, Biceps Femoris, and Semitendinosus, during overground walk. | Gait analysis test at week 1 with 5 trials of overground walking at a speed of 1.4 m/s | |
Primary | Muscle EMG activity | Unilateral Surface Electromyography of Medial Gastrocnemius, Lateral Gastrocnemius, Vastus Medialis, Vastus Lateralis, Tibialis Anterior, Peroneus Longus, Soleus, Biceps Femoris, and Semitendinosus, during overground walk. | Gait analysis test at week 6 with 5 trials of overground walking at a speed of 1.4 m/s | |
Primary | Maximum Vertical Jump | Height (m) of center of mass above ground measured by markers place on posterior superior iliac spine. | 2 - 3 hours on week 1 | |
Primary | Maximum Vertical Jump | Height (m) of center of mass above ground measured by markers place on posterior superior iliac spine. | 2 - 3 hours on week 6 | |
Primary | Self-reported shoe comfort | Shoe wear and comfort log | Week 0, 5 minutes | |
Primary | Self-reported pain, and injury. | Injury and pain log | Week 0, 5 minutes | |
Primary | Self-reported shoe comfort | Shoe wear and comfort log | Week 2, 5 minutes | |
Primary | Self-reported pain, and injury. | Injury and pain log | Week 2, 5 minutes | |
Primary | Self-reported shoe comfort | Shoe wear and comfort log | Week 4, 5 minutes | |
Primary | Self-reported pain, and injury. | Injury and pain log | Week 4, 5 minutes | |
Primary | Self-reported shoe comfort | Shoe wear and comfort log | Week 6, 5 minutes | |
Primary | Self-reported pain, and injury. | Injury and pain log | Week 6, 5 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03802578 -
The Impact of Exercise on Hand Function, Daily Activities Performance and Quality of Life of SLE' Patients
|
N/A | |
Completed |
NCT01896050 -
Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancer
|
N/A | |
Recruiting |
NCT04354649 -
Immune-Mediated Pathophysiology And Clinical Triage Program
|
Phase 2 | |
Terminated |
NCT00973141 -
A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain
|
Phase 2 | |
Recruiting |
NCT05564182 -
High Intensity Laser Therapy in the Treatment of Hemiplegic Shoulder Pain
|
N/A | |
Recruiting |
NCT05033613 -
Home Blood Pressure Monitoring Before and After COVID-19 Vaccination in Patients at High Risk of Cardiovascular Disease
|
||
Recruiting |
NCT03953157 -
Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors
|
N/A | |
Not yet recruiting |
NCT06001125 -
Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1)
|
Phase 2 | |
Terminated |
NCT02947022 -
Effects of IV-Administered Ca-DTPA and Zn-DTPA To Treat Patients With Gadolinium Deposition Disease
|
Phase 1/Phase 2 | |
Terminated |
NCT02047851 -
Randomized, Blinded, Sham-controlled Trial of Acupuncture for the Management of Joint Pain in Patients With Psoriasis
|
N/A | |
Withdrawn |
NCT01612728 -
Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer
|
Phase 2 | |
Completed |
NCT02118636 -
Observational Study to Evaluate Mechanisms of Aromatase Inhibitor Associated Musculoskeletal Symptoms
|
N/A | |
Completed |
NCT00361582 -
A Study to Evaluate the Effectiveness and Safety of Multiple Doses of Tapentadol(CG5503) in Patients Awaiting Joint Replacement Surgery
|
Phase 3 | |
Completed |
NCT00416715 -
Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer
|
Phase 2 | |
Completed |
NCT02831582 -
Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer
|
N/A | |
Recruiting |
NCT04494412 -
An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection
|
Phase 2 | |
Not yet recruiting |
NCT06134050 -
Finding the Optimal Aim of Correction in Opening Wedge High Tibial Osteotomy
|
N/A | |
Completed |
NCT02589249 -
The Effect of AyuFlex® Supplementation on Joint Health
|
N/A | |
Completed |
NCT02778906 -
Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia
|
Phase 3 | |
Terminated |
NCT01096407 -
Role of Biomarkers in Muscle Pain and Joint Pain in Patients With Solid Tumors Receiving Paclitaxel
|
Phase 1 |